Educational

BPC-157 + TB-500

Commonly discussed for: soft-tissue and injury recovery

That is what people say it is for, not a finding. Nothing on this page is a recommendation to take this combination.

Almost no published research on this combination.

A PubMed search requiring all of these compounds together returns only a handful of results — and a paper mentioning two compounds is usually a review discussing them separately, not a study of them taken together.

Papers on the combination10

Papers on BPC-157 alone230

Papers on TB-500 alone1,055

Live counts from PubMed (U.S. National Library of Medicine), refreshed daily. A count is a measure of how much has been published, not of whether something works.

Query: ("BPC-157" OR "body protection compound 157") AND ("TB-500" OR "thymosin beta 4"). Compounds are searched under every name they are published as, so a compound better known in the literature by another name (TB-500 is published as thymosin beta-4) is counted under both.

Documented safety considerations

Neither compound is FDA-approved for human use. BPC-157 appears on the FDA's Category 2 list of bulk drug substances presenting significant safety risks for compounding, meaning a licensed pharmacy generally cannot legally compound it.

Read up on each compound

We publish no doses, ratios, durations, or cycle lengths for any combination. Those numbers do not exist in the research, and inventing them would be dangerous. This page is educational only and is not medical advice. Talk to a licensed clinician.